-
1.发明申请HYPERLIPEMIA-AMELIORATING AGENT, ANEMIA-AMELIORATING COMPOSITION, URIC-ACID-LEVEL-REDUCING COMPOSITION, AND FOOD OR BEVERAGE 有权超临界改性剂，抗氧化剂组合物，尿酸 - 水平降低组合物，食品或饮料公开(公告)号：US20130131025A1
公开(公告)日：2013-05-23
申请号：US13738234
申请日：2013-01-10
CPC分类号： A61K31/58 , A61K31/57 , A61K31/575 , C07J9/00 , C07J17/00 , C07J17/005
摘要： A neutral-fat-level-regulating agent, a cholesterol-level-regulating agent, a free-fatty-acid-level-regulating agent or an anti-obesity agent, including: at least one of protopanaxatriol, panaxatriol, protopanaxadiol and panaxadiol which are aglycons of dammarane-type saponins and a hyperlipemia-ameliorating agent including: at least one of the neutral-fat-level-regulating agent, the cholesterol-level-regulating agent, the free-fatty-acid-level-regulating agent and the anti-obesity agent.
摘要翻译： 中性脂肪水平调节剂，胆固醇水平调节剂，游离脂肪酸水平调节剂或抗肥胖剂，包括：原头三甲三醇，panax三醇，原人参二醇和泛二醇中的至少一种， 是血液型皂苷和高脂血症改善剂的副产物，其包括：至少一种中性脂肪水平调节剂，胆固醇水平调节剂，游离脂肪酸水平调节剂和 抗肥胖剂。
-
公开(公告)号：US20120252768A1
公开(公告)日：2012-10-04
申请号：US13495031
申请日：2012-06-13
CPC分类号： A61K31/58 , A23L2/52 , A23L33/105 , A23V2002/00 , A61K31/575 , A61K2300/00 , A23V2200/308 , A23V2200/328
摘要： A composition including: at least one mixture selected from the group consisting of a mixture of (A) panaxatriol and (B) protopanaxatriol and a mixture of (C) panaxadiol and (D) protopanaxadiol, wherein a ratio (A)/(B) of a mass of the (A) panaxatriol to a mass of the (B) protopanaxatriol is 1 or greater, and a ratio (C)/(D) of a mass of the (C) panaxadiol to a mass of the (D) protopanaxadiol is 1 or greater.
摘要翻译： 一种组合物，其包含：选自（A）百里酚三醇和（B）原人参三醇的混合物和（C）二羟基二醇和（D）原人参二醇的混合物中的至少一种混合物，其中比率（A）/（B） （A）百古三醇与（B）原人参三醇的质量的质量比为（1）或更大，（C）二聚二醇的质量与（D）的质量的比（C）/（D） 原人参二醇是1或更大。
-
3.发明授权Hyperlipemia-ameliorating agent, anemia-ameliorating composition, uric-acid-level-reducing composition, and food or beverage 有权高脂血症改善剂，贫血改善组合物，尿酸水平降低组合物和食品或饮料公开(公告)号：US08927033B2
公开(公告)日：2015-01-06
申请号：US13738234
申请日：2013-01-10
IPC分类号： A61K36/258 , A61K36/00 , A61K31/58 , A61K31/575 , C07J9/00 , C07J17/00 , A61K31/57
CPC分类号： A61K31/58 , A61K31/57 , A61K31/575 , C07J9/00 , C07J17/00 , C07J17/005
摘要： A neutral-fat-level-regulating agent, a cholesterol-level-regulating agent, a free-fatty-acid-level-regulating agent or an anti-obesity agent, including: at least one of protopanaxatriol, panaxatriol, protopanaxadiol and panaxadiol which are aglycons of dammarane-type saponins and a hyperlipemia-ameliorating agent including: at least one of the neutral-fat-level-regulating agent, the cholesterol-level-regulating agent, the free-fatty-acid-level-regulating agent and the anti-obesity agent.
摘要翻译： 中性脂肪水平调节剂，胆固醇水平调节剂，游离脂肪酸水平调节剂或抗肥胖剂，包括：原头三甲三醇，panax三醇，原人参二醇和泛二醇中的至少一种， 是血液型皂苷和高脂血症改善剂的副产物，其包括：至少一种中性脂肪水平调节剂，胆固醇水平调节剂，游离脂肪酸水平调节剂和 抗肥胖剂。
-
4.发明申请HYPERLIPEMIA-AMELIORATING AGENT, ANEMIA-AMELIORATING COMPOSITION, URIC-ACID-LEVEL-REDUCING COMPOSITION, AND FOOD OR BEVERAGE 审中-公开超临界改性剂，抗氧化剂组合物，尿酸 - 水平降低组合物，食品或饮料公开(公告)号：US20120258184A1
公开(公告)日：2012-10-11
申请号：US13527729
申请日：2012-06-20
CPC分类号： A61K31/58 , A61K31/57 , A61K31/575 , C07J9/00 , C07J17/00 , C07J17/005
摘要： A neutral-fat-level-regulating agent, a cholesterol-level-regulating agent, a free-fatty-acid-level-regulating agent or an anti-obesity agent, including: at least one of protopanaxatriol, panaxatriol, protopanaxadiol and panaxadiol which are aglycons of dammarane-type saponins; and a hyperlipemia-ameliorating agent including: at least one of the neutral-fat-level-regulating agent, the cholesterol-level-regulating agent, the free-fatty-acid-level-regulating agent and the anti-obesity agent.
摘要翻译： 中性脂肪水平调节剂，胆固醇水平调节剂，游离脂肪酸水平调节剂或抗肥胖剂，包括：原头三甲三醇，panax三醇，原人参二醇和泛二醇中的至少一种， 是dammarane型皂苷的副产物; 和高脂血症改善剂，其包含：中性脂肪水平调节剂，胆固醇水平调节剂，游离脂肪酸水平调节剂和抗肥胖剂中的至少一种。
-
5.发明申请GLUCOSE METABOLISM-IMPROVING AGENT AND GLUCOSE METABOLISM-IMPROVING COMPOSITION 审中-公开葡萄糖代谢改善剂和葡萄糖代谢改善组合物公开(公告)号：US20120116069A1
公开(公告)日：2012-05-10
申请号：US13324359
申请日：2011-12-13
IPC分类号： C07J17/00
摘要： A sugar metabolism-improving agent including at least one of a compound having a structure expressed by the following Structural Formula (1) and a compound having a structure expressed by the following Structural Formula (2).
摘要翻译： 一种糖代谢改善剂，其包含具有由以下结构式（1）表示的结构的化合物和具有由以下结构式（2）表示的结构的化合物中的至少一种。
-
-
-
-
搜索结果
5 条记录 (耗时 0.015 秒)
